Tumor initiation cells or cancer stem cell markers ABCG2 and ALDH1 play pivotal roles in invasion, metastasis and resistance to cytotoxic agents. In this study, we evaluated the expression levels of ALDH1 and ABCG2 in Iraqi patients with colon cancer and/or benign colon tumors. We also investigated the association between the expression levels of these markers and patient clincopathological features. The expression levels of ALDH1 and ABCG2 in cancer tissues as well as in benign tumor samples were determined by immunohistochemistry using tumor tissues microarray of TNM (Tumor, Node, Metastasis) in 42 patients with colon cancer samples as well as in 18 corresponding benign tumors. Immunohistochemistry showed that ALDH1 and ABCG2 expression levels increased to 80% and 76%, respectively in colon cancer tissues as compared to 33% and 28% in benign tumor tissues. The expression levels of ALDH1 and ABCG2 were associated with tumor stages. No significant association was found between the expressions levels of these markers and tumor size, gender, patients' age, and lymph node involvement.
chemo-radiotherapy agents may reduce the volume of tumor without affecting CSCs. Therefore, patients may suffer from cancer retrogression.
These cells can be identified and separated from different solid tumors by using putative CSC markers (6) . In this study, the expression levels of CSC markers aldehyde dehydrogenase 1 (ALDH1) and ATP-binding cassette super-family G member 2 (ABCG2) were determined in Iraqi patients with colon cancer, and the association between the expression levels of these markers and tumor stages, lymph node involvement, patient's age and gender were examined. 
Materials and Methods

Patients and tumor characteristics
Results
Protein expression of ALDH1 and ABCG2
Immunohistochemistry data showed that ALDH1 and ABCG2 levels were higher in colon cancer in comparison with benign tumors (Table 2) . 
Relationship between ALDH1 and ABCG2 expression levels and patient clinical features
The results of biological markers are presented in On the other hand, it is well known that many cancers are not sensitive to conventional chemotherapy, and this is in particular correct in In this study, we found that ALDH1 was highly expressed in colon cancer tissues as In conclusion, the present study showed that Moreover, results showed that protein expression of ABCG2 was elevated in colon cancer tissues compared with non-cancerous tissues. Together, these results suggest that ALDH1 and ABCG2 may be used as biochemical markers in diagnosis and prognosis of colon cancer.
